Valuation: Alembic Pharmaceuticals Limited

Market Cap 207B 2.21B 2.01B 1.85B 1.67B 3.16B 3.28B 22.34B 8.83B 111B 8.29B 8.12B 352B P/E 2027 *
23.2x
P/E 2028 * 19.7x
Enterprise Value 216B 2.31B 2.1B 1.94B 1.75B 3.3B 3.42B 23.33B 9.23B 116B 8.66B 8.48B 368B EV / Sales 2027 *
2.38x
EV / Sales 2028 * 2.19x
Free-Float
29.3%
Yield 2027 *
1.33%
Yield 2028 * 1.49%
1 day-0.60%
1 week+1.40%
Current month+30.90%
1 month+32.14%
3 months+26.66%
6 months+44.17%
Current year+23.42%
1 week 1,024.15
Extreme 1024.15
1,075
1 month 748.25
Extreme 748.25
1,075
Current year 635.8
Extreme 635.8
1,075
1 year 635.8
Extreme 635.8
1,075
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Chief Executive Officer 48 30/03/2026
Chief Executive Officer 51 30/03/2026
Director of Finance/CFO - 06/07/2025
Director TitleAgeSince
Chairman 78 07/06/2012
Director/Board Member 51 31/12/2006
Director/Board Member 66 17/01/2003
Date Insider Type Main position Quantity % Market Cap. Importance
28/03/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/03/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/03/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%+1.40%+14.32%+39.39% 2.21B
-1.13%-1.17%+38.55%+139.23% 1,261B
-1.36%-0.74%+39.64%+86.06% 671B
-0.59%-0.36%+25.14%+111.73% 518B
+0.04%+0.87%+32.18%+70.95% 387B
-0.75%-3.16%+54.39%+40.90% 353B
-0.44%-0.08%+30.04%+57.38% 300B
-0.57%-1.32%+1.08%+35.68% 283B
-0.95%-1.57%+34.01%+72.55% 248B
+1.60%-0.36%+37.21%+125.66% 211B
Average -0.18%+0.06%+30.66%+77.95% 423B
Weighted average by Cap. -0.20%-0.54%+34.37%+95.64%

Financials

2027 *2028 *
Net sales 90.66B 970M 881M 814M 734M 1.39B 1.44B 9.81B 3.88B 48.92B 3.64B 3.56B 155B 97.04B 1.04B 943M 871M 786M 1.48B 1.54B 10.5B 4.15B 52.37B 3.9B 3.81B 165B
Net income 8.86B 94.83M 86.09M 79.53M 71.74M 135M 141M 958M 379M 4.78B 356M 348M 15.11B 10.39B 111M 101M 93.24M 84.11M 159M 165M 1.12B 444M 5.61B 417M 408M 17.71B
Net Debt 9.23B 98.76M 89.65M 82.82M 74.71M 141M 146M 998M 395M 4.98B 371M 363M 15.73B 6.47B 69.29M 62.9M 58.11M 52.42M 98.96M 103M 700M 277M 3.49B 260M 254M 11.04B
Projected Income Statement - Annual - Alembic Pharmaceuticals Limited
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
18/11/26 ₹1,044.35 -0.60% 228,735
17/11/26 ₹1,050.65 -0.61% 201,850
16/11/26 ₹1,057.10 +2.62% 452,099
13/11/26 ₹1,030.15 -1.63% 422,868
12/11/26 ₹1,047.25 +1.68% 452,715
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Alembic Pharmaceuticals Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,050.65INR
Average target price
1,075.90INR
Spread / Average Target
+2.40%
  1. Stock Market
  2. Stocks
  3. APLLTD Stock